Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Percutaneous endoscopic gastrostomy risks rendering the gastric conduit unusable for esophagectomy.

Ohnmacht GA, Allen MS, Cassivi SD, Deschamps C, Nichols FC 3rd, Pairolero PC.

Dis Esophagus. 2006;19(4):311-2.

PMID:
16866867
2.

Failed antireflux surgery: results after reoperation.

Ohnmacht GA, Deschamps C, Cassivi SD, Nichols FC 3rd, Allen MS, Schleck CD, Pairolero PC.

Ann Thorac Surg. 2006 Jun;81(6):2050-3; discussion 2053-4.

PMID:
16731129
3.

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration.

Panelli MC, Wang E, Phan G, Puhlmann M, Miller L, Ohnmacht GA, Klein HG, Marincola FM.

Genome Biol. 2002 Jun 25;3(7):RESEARCH0035. Epub 2002 Jun 25.

4.

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

Wang E, Miller LD, Ohnmacht GA, Mocellin S, Perez-Diez A, Petersen D, Zhao Y, Simon R, Powell JI, Asaki E, Alexander HR, Duray PH, Herlyn M, Restifo NP, Liu ET, Rosenberg SA, Marincola FM.

Cancer Res. 2002 Jul 1;62(13):3581-6.

5.

Melanoma-Reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor types.

Harada M, Li YF, El-Gamil M, Ohnmacht GA, Rosenberg SA, Robbins PF.

J Immunother. 2001 Jul-Aug;24(4):323-33.

PMID:
11565834
6.

Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading.

Lally KM, Mocellin S, Ohnmacht GA, Nielsen MB, Bettinotti M, Panelli MC, Monsurro V, Marincola FM.

Int J Cancer. 2001 Sep;93(6):841-7.

7.

Short-term kinetics of tumor antigen expression in response to vaccination.

Ohnmacht GA, Wang E, Mocellin S, Abati A, Filie A, Fetsch P, Riker AI, Kammula US, Rosenberg SA, Marincola FM.

J Immunol. 2001 Aug 1;167(3):1809-20.

8.

Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas.

Hanada K, Perry-Lalley DM, Ohnmacht GA, Bettinotti MP, Yang JC.

Cancer Res. 2001 Jul 15;61(14):5511-6.

9.

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2.

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.

J Immunother (1991). 2001 Mar;24(2):188-192.

PMID:
11449076
10.

Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness.

Mocellin S, Ohnmacht GA, Wang E, Marincola FM.

Int J Cancer. 2001 Jul 15;93(2):236-42.

11.

A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2.

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.

J Immunother. 2001 Mar-Apr;24(2):188-92.

PMID:
11265777
12.

Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.

Weiser TS, Guo ZS, Ohnmacht GA, Parkhurst ML, Tong-On P, Marincola FM, Fischette MR, Yu X, Chen GA, Hong JA, Stewart JH, Nguyen DM, Rosenberg SA, Schrump DS.

J Immunother. 2001 Mar-Apr;24(2):151-61.

PMID:
11265773
13.

Induction of MAGE-3 expression in lung and esophageal cancer cells.

Weiser TS, Ohnmacht GA, Guo ZS, Fischette MR, Chen GA, Hong JA, Nguyen DM, Schrump DS.

Ann Thorac Surg. 2001 Jan;71(1):295-301; discussion 301-2.

PMID:
11216765
14.

A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.

Panelli MC, Bettinotti MP, Lally K, Ohnmacht GA, Li Y, Robbins P, Riker A, Rosenberg SA, Marincola FM.

J Immunol. 2000 Apr 15;164(8):4382-92.

15.

Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.

Riker AI, Kammula US, Panelli MC, Wang E, Ohnmacht GA, Steinberg SM, Rosenberg SA, Marincola FM.

Int J Cancer. 2000 Jun 15;86(6):818-26.

16.

High-fidelity mRNA amplification for gene profiling.

Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM.

Nat Biotechnol. 2000 Apr;18(4):457-9.

PMID:
10748532
17.

Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.

Ohnmacht GA, Marincola FM.

J Cell Physiol. 2000 Mar;182(3):332-8. Review.

PMID:
10653599
18.

Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens.

Kammula US, Lee KH, Riker AI, Wang E, Ohnmacht GA, Rosenberg SA, Marincola FM.

J Immunol. 1999 Dec 15;163(12):6867-75.

Supplemental Content

Loading ...
Support Center